Literature DB >> 25645403

Inter-rater agreement of sputum cytology for lung cancer screening in Japan.

Chiaki Endo1, Ryutaro Nakashima2, Akemi Taguchi3, Kazunobu Yahata4, Ei Kawahara5, Nikako Shimagaki6, Junko Kamio7, Yasuki Saito8, Norihiko Ikeda9, Masami Sato10.   

Abstract

BACKGROUND: To compare lung cancer detection rate by sputum cytology, we need some assurance that the estimates do not vary widely if different observers evaluate the same specimens. The aim of this study was to determine inter-rater agreement of sputum cytology diagnoses.
METHODS: Slides of sputum cytology from 150 subjects were selected from a pool of slides held by six of the laboratories that had participated in a population-based lung cancer screening program over the last ten years in Japan. The cytotechnologists in these laboratories had considerable experience with sputum cytology. Each case was re-evaluated six times. Cases that were diagnosed as the same category by all six laboratories were selected as consensus cases to serve as standardized sputum cytology cases. Thirty-seven cytotechnologists with various levels of experience in sputum cytology then re-evaluated these consensus cases. Inter-rater agreement was calculated by kappa statistics including Fleiss' kappa.
RESULTS: All pairs of interlaboratory agreement for the 150 cases showed statistically significant kappa values, most pairs showing substantial agreement. Fleiss' kappa value across the six laboratories was 0.5. Fourteen cases were identified as the consensus cases, and the agreement among observers with less experience of sputum cytology showed significantly lower than the agreement among those with considerable experience (Fleiss' kappa value 0.27 vs. 0.45, P < 0.05). Moreover, cytotechnologists with less experience under-diagnosed the slides significantly more often than those with considerable experience.
CONCLUSION: When the observers have considerable experience with sputum cytology, inter-observer agreement is good.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fleiss’; interrater agreement; kappa; kappa statistics; lung cancer screening; quality assurance; sputum cytology

Mesh:

Year:  2015        PMID: 25645403     DOI: 10.1002/dc.23253

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs.

Authors:  Kei Morikawa; Kohei Kinoshita; Hirotaka Kida; Takeo Inoue; Masamichi Mineshita
Journal:  Genes (Basel)       Date:  2022-05-02       Impact factor: 4.141

2.  Neutral Desorption Extractive Electrospray Ionization Mass Spectrometry Analysis Sputum for Non-Invasive Lung Adenocarcinoma Detection.

Authors:  Qiaoling Zheng; Jianyong Zhang; Xinchen Wang; Wenxiong Zhang; Yipo Xiao; Sheng Hu; Jianjun Xu
Journal:  Onco Targets Ther       Date:  2021-01-15       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.